TRILLIUM ASSET MANAGEMENT, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRILLIUM ASSET MANAGEMENT, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$572,000
-41.5%
6,005
-31.4%
0.02%
-42.9%
Q2 2020$978,000
+50.5%
8,748
-2.1%
0.04%
+23.5%
Q1 2020$650,000
-30.4%
8,932
-0.3%
0.03%
-19.0%
Q4 2019$934,000
-0.7%
8,957
-5.2%
0.04%
-4.5%
Q3 2019$941,000
-11.9%
9,451
+1.0%
0.04%
-15.4%
Q2 2019$1,068,000
+3.1%
9,355
+13.5%
0.05%0.0%
Q1 2019$1,036,000
+74.1%
8,245
+88.0%
0.05%
+52.9%
Q4 2018$595,000
-48.6%
4,386
+4.1%
0.03%
-41.4%
Q3 2018$1,157,000
+27.8%
4,215
-3.5%
0.06%
+20.8%
Q2 2018$905,000
+24.7%
4,370
-0.5%
0.05%
+20.0%
Q1 2018$726,000
+16.2%
4,394
-3.7%
0.04%
+17.6%
Q4 2017$625,000
+0.5%
4,562
-0.2%
0.03%
-5.6%
Q3 2017$622,000
+13.5%
4,570
+1.3%
0.04%
+9.1%
Q2 2017$548,000
+20.2%
4,511
+4.7%
0.03%
+13.8%
Q1 2017$456,000
+14.3%
4,309
+9.7%
0.03%
+11.5%
Q4 2016$399,000
+9.3%
3,929
+9.8%
0.03%
+13.0%
Q3 2016$365,0003,5790.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders